Electroconvulsive therapy for severe neuropsychiatric lupus with psychosis

Journal of ECT

Volumn 29, Issue 3, 2013, Pages 243-246

  Tan, Lynnette Pei Lin ^a   Tan, Lynnette Ee Sing ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Electroconvulsive therapy; NPSLE; SLE psychosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; FLUOXETINE; HALOPERIDOL; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LORAZEPAM; METHYLPREDNISOLONE; NEUROLEPTIC AGENT; OLANZAPINE; PREDNISOLONE; RISPERIDONE;

ADULT; AGITATION; ALOPECIA; ARTHRITIS; ARTICLE; AUDITORY HALLUCINATION; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; LABORATORY DIAGNOSIS; LEG SWELLING; MALAISE; MINI MENTAL STATE EXAMINATION; NEPHRITIS; PHYSICAL EXAMINATION; PSYCHOSIS; RASH; RELAPSE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VISUAL HALLUCINATION; VOMITING;

ADRENAL CORTEX HORMONES; ADULT; ANESTHESIA; ANTI-INFLAMMATORY AGENTS; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLOPHOSPHAMIDE; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; TREATMENT OUTCOME;

EID: 84883560017     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182809c01     Document Type: Article

References (24)

1. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology. 2002;58:1214-1220
2. American College of Rheumatology Ad Hoc Committee on Neuropsychiatric Lupus Syndromes. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599-608
3. Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57:496-500
4. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28:766-771
5. Bodani M, Kopelman MD. A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus. Lupus. 2003;12: 947-949
6. Pinto JP, Morais SL, Hallak JE, et al. Effectiveness of olanzapine for systemic lupus erythematosusYrelated psychosis. Prim Care Companion J Clin Psychiatry. 2006;8:377-378
7. Furmaga KM, DeLeon OA, Sinha SB, et al. Psychosis in medical conditions: Response to risperidone. Gen Hosp Psychiatry. 1997;19:223-228
8. Fricchione GL, Kaufman LD, Gruber BL, et al. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med. 1990;88:442-443
9. Ditmore BG, Malek-Ahmadi P, Mills DM, et al. Manic psychosis and catatonia stemming from systemic lupus erythematosus: Response to ECT. Convuls Ther. 1992;8:33-37
10. Fam J, Lee TS, Lee HY, et al. Electroconvulsive therapy for catatonia in neuropsychiatric systemic lupus erythematosus. J ECT. 2010;26: 143-144
11. Allen RE, Pitts FN Jr. ECT for depressed patients with lupus erythematosus. Am J Psychiatry. 1978;135:367-368
12. Douglas CJ, Schwartz HI. ECT for depression caused by lupus cerebritis: A case report. Am J Psychiatry. 1982;139:1631-1632
13. Fessel WJ, Solomon GF. Psychosis and systemic lupus erythematosus: A review of the literature and case reports. Calif Med. 1960;92: 266-270
14. Baca V, Lavalle C, Garcia R, et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol. 1999;26:432-439
15. Mak A, Ho CMR, Lau CS. Clinical implications of neuropsychiatric systemic lupus erythematosus. Advances in Psychiatric Treatment. 2009;15:451-458
16. Nishimura K, Omori M, Horikawa N, et al. Risperidone in the treatment of acute confusional state (delirium) due to neuropsychiatric lupus erythematosus: Case report. Int J Psychiatry Med. 2003;33:299-303
17. Guze SB. The occurrence of psychiatric illness in systemic lupus erythematosus. Am J Psychiatry. 1967;123:1562-1570
18. Levin L,Wambold D, Viguera A, et al. Hemodynamic responses to ECT in a patient with critical aortic stenosis. J ECT. 2000;16:52-61
19. Malur C, Pasol E, Francis A. ECT for prolonged catatonia. J ECT. 2001;17:55-59
20. Mac DS, Pardo MP. Systemic lupus erythematosus and catatonia: A case report. J Clin Psychiatry. 1983;44:155-156
21. Bizon E. [Case of chronic schizophrenia with long-term catatonia treated with electroconvulsant therapy]. Psychiatr Pol. 1972;6:97-99
22. Kurokawa Y, Ueno T, Obara T, et al. [Hyperkinetic mutism within the scope of consciousness disorder in a case of systemic lupus erythematosus]. Jpn J Psychiatry Neurol. 1989;43:89-96
23. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001
24. National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy. NICE Technology Appraisal Guidance 59. London, UK: National Institute for Clinical Excellence; 2003